SARS-CoV-2 Neutralizing Antibodies Kinetics Postvaccination in Cancer Patients under Treatment with Immune Checkpoint Inhibition

SIMPLE SUMMARY: Solid tumor patients under active anticancer treatment are peculiarly affected by COVID-19 infection, given not only its ominous outcomes but also the need of disruptions of their rather strict therapeutic scheme. Thus, they have been globally prioritized for both primary and booster...

Descripción completa

Detalles Bibliográficos
Autores principales: Terpos, Evangelos, Liontos, Michalis, Fiste, Oraianthi, Zagouri, Flora, Briasoulis, Alexandros, Sklirou, Aimilia D., Markellos, Christos, Skafida, Efthymia, Papatheodoridi, Alkistis, Andrikopoulou, Angeliki, Koutsoukos, Konstantinos, Kaparelou, Maria, Iconomidou, Vassiliki A., Trougakos, Ioannis P., Dimopoulos, Meletios-Athanasios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179468/
https://www.ncbi.nlm.nih.gov/pubmed/35681774
http://dx.doi.org/10.3390/cancers14112796

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179468/
https://www.ncbi.nlm.nih.gov/pubmed/35681774
http://dx.doi.org/10.3390/cancers14112796

Ejemplares similares